Multigene assays to improve assessment of recurrence risk and benefit from chemotherapy in early-stage colon cancer: has the time finally arrived, or are we still stage locked?

J Clin Oncol. 2010 Sep 1;28(25):3904-7. doi: 10.1200/JCO.2010.30.0806. Epub 2010 Aug 2.
No abstract available

Publication types

  • Comment
  • Editorial

MeSH terms

  • Chemotherapy, Adjuvant*
  • Colonic Neoplasms / drug therapy*
  • Colonic Neoplasms / genetics*
  • Colonic Neoplasms / pathology
  • Gene Expression Profiling*
  • Humans
  • Neoplasm Staging
  • Prognosis
  • Recurrence